期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma
1
作者 Qiaonan Shan Lu Yin +20 位作者 Qifan Zhan Jiongjie Yu Sheng Pan Jianyong Zhuo Wei Zhou jiaqi bao Lincheng Zhang Jiachen Hong Jianan Xiang Qingyang Que Kangchen Chen Shengjun Xu Jingrui Wang Yangbo Zhu Bin He Jingbang Wu Haiyang Xie Shusen Zheng Tingting Feng Sunbin Ling Xiao Xu 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2024年第10期4614-4627,共14页
Lenvatinib is a targeted drug used for first-line treatment of hepatocellular carcinoma(HCC).A deeper insight into the resistance mechanism of HCC against lenvatinib is urgently needed.In this study,we aimed to dissec... Lenvatinib is a targeted drug used for first-line treatment of hepatocellular carcinoma(HCC).A deeper insight into the resistance mechanism of HCC against lenvatinib is urgently needed.In this study,we aimed to dissect the underlying mechanism of lenvatinib resistance(LR)and provide effective treatment strategies.We established an HCC model of acquired LR.Cell counting,migration,self-renewal ability,chemoresistance and expression of stemness genes were used to detect the stemness of HCC cells.Molecular and biochemical strategies such as RNA-sequencing,immunoprecipitation,mass spectrometry and ubiquitination assays were used to explore the underlying mechanisms.Patient-derived HCC models and HCC samples from patients were used to demonstrate clinical significance.We identified that increased cancer stemness driven by the hypoxia-inducible factor-1α(HIF-1α)pathway activation is responsible for acquired LR in HCC.Phosphorylated non-muscle myosin heavy chain 9(MYH9)at Ser1943,p-MYH9(Ser1943),could recruit ubiquitin-specific protease 22(USP22)to deubiquitinate and stabilize HIF-1αin lenvatinib-resistant HCC.Clinically,p-MYH9(Ser1943)expression was upregulated in HCC samples,which predicted poor prognosis and LR.A casein kinase-2(CK2)inhibitor and a USP22 inhibitor effectively reversed LR in vivo and in vitro.Therefore,the p-MYH9(Ser1943)/USP22/HIF-1αaxis is critical for LR and cancer stemness.For the diagnosis and treatment of LR in HCC,p-MYH9(Ser1943),USP22,and HIF-1αmight be valuable as novel biomarkers and targets. 展开更多
关键词 USP22 HEPATOCELLULAR diagnosis
原文传递
Professor Cuifen Huang: a great molecular geneticist and the founder of genetic engineering in China
2
作者 Wei Gong Leyi Cui +2 位作者 Yike Ying Yijing Shen jiaqi bao 《Protein & Cell》 SCIE CAS CSCD 2021年第3期159-161,共3页
Professor Cuifen Huang(黄翠芬,1921-2011)is a famous molecular geneticist and one of the founders of Genetic Engineering in China(Fig.1).She devoted all her life to researches on genetic engineering of vaccines and pol... Professor Cuifen Huang(黄翠芬,1921-2011)is a famous molecular geneticist and one of the founders of Genetic Engineering in China(Fig.1).She devoted all her life to researches on genetic engineering of vaccines and polypeptide drugs and studies on molecular tumors.She made tremendous contributions to the development of biotechnology and military medical science in China.She was also the first scientist who cloned and expressed the pro-urokinase gene in China which showed high selective thrombolysis without systemic hemorrhage(Chinese Academy of Engineering,2009). 展开更多
关键词 devoted DRUGS FOUNDER
原文传递
Professor Haowen Xu:The founder of exercise biochemistry in China
3
作者 Wei Gong Yijing Shen +3 位作者 jiaqi bao Yike Ying Han Zhou Zhifeng Wu 《Protein & Cell》 SCIE CSCD 2021年第10期747-750,共4页
Professor Haowen Xu(许豪文,1935-2004)was a famous sports scientist and the founder of Exercise Biochemistry in China(Fig.1).He dedicated his life to the study of sports science and made tremendous contributions to the... Professor Haowen Xu(许豪文,1935-2004)was a famous sports scientist and the founder of Exercise Biochemistry in China(Fig.1).He dedicated his life to the study of sports science and made tremendous contributions to the formation and growth of the field of Exercise Biochemistry in China.He was the first to use theories of exercise biochemistry and sports medicine to guide athletes'training and competition in China(Yu,2006). 展开更多
关键词 China SPORTS BIOCHEMISTRY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部